Iwami K.a· Nomura T.a· Seo S.a· Nojima S.a· Tsuzaka K.a· Kimura A.b· Shimohata T.b· Yabe I.c

Author affiliations

aDepartment of Neurology, Kushiro Rosai Hospital, Kushiro, Japan
bDepartment of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan
cDepartment of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: December 16, 2021
Accepted: March 10, 2022
Published online: April 14, 2022

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 1

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: https://www.karger.com/NIM

Abstract

Introduction: Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a recently described steroid-responsive meningoencephalomyelitis positive for cerebrospinal fluid (CSF) anti-GFAP antibody. Area postrema syndrome (APS) involves intractable hiccups, nausea, and vomiting, which is caused by medulla oblongata (MO) impairment. APS is a characteristic symptom of aquaporin-4 (AQP4) autoimmunity, and it helps to differentiate between AQP4 and GFAP autoimmunity. Conversely, although 6 cases of autoimmune GFAP astrocytopathy with APS and MO lesions have been reported, the association between GFAP autoimmunity and APS is unclear. We report the case of a patient with autoimmune GFAP astrocytopathy presenting with APS-like symptoms without MO lesions and discuss the mechanisms underlying the symptoms. Methods: CSF anti-GFAP antibody was detected using cell-based assays and immunohistochemical assays. Results: A 54-year-old Japanese man developed persistent hiccups, intermittent vomiting, fever, anorexia, and inattention. Brain magnetic resonance imaging (MRI) showed periventricular lesions with radial linear periventricular enhancement, suggesting autoimmune GFAP astrocytopathy. However, no obvious MO lesions were identified on thin-slice images. Spinal cord MRI revealed hazy lesions with patchy enhancement along the cervical and thoracic cord. CSF analysis demonstrated inflammation, with positive results for anti-GFAP antibodies. Anti-AQP4 antibodies in the serum and CSF were negative. Esophagogastroduodenoscopy revealed gastroparesis and gastroesophageal reflux disease, and vonoprazan, mosapride, and rikkunshito were effective only against persistent hiccups. Steroid therapy was initiated, allowing clinical and radiological improvements. Repeated MRIs demonstrated no obvious MO lesions. Conclusion: This report suggests that autoimmune GFAP astrocytopathy presents with APS-like symptoms without obvious MO lesions. The possible causes of hiccups were gastroparesis and cervical cord lesions. Gastroesophageal reflux disease was not considered a major cause of the hiccups. Intermittent vomiting appeared to be associated with gastroparesis, cervical cord lesions, and viral-like symptoms. Testing for anti-GFAP antibodies should be considered in patients with APS-like symptoms in the context of typical clinical-MRI features of autoimmune GFAP astrocytopathy.

© 2022 S. Karger AG, Basel

References Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016 Nov;73(11):1297–307. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin Gas biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017 Feb;81(2):298–309. Xiao J, Chen X, Shang K, Tang Y, Chen M, Deng G, et al. Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: a pooled analysis of 324 cases from published data and a single-center retrospective study. J Neuroimmunol. 2021 Nov;360:577718. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev. 2007 Nov;56(1):119–47. Steger M, Schneemann M, Fox M. Systemic review: the pathogenesis and pharmacological treatment of hiccups. Aliment Pharmacol Ther. 2015 Nov;42(9):1037–50. Camara-Lemarroy CR, Burton JM. Area postrema syndrome: a short history of a pearl in demyelinating diseases. Mult Scler. 2019 Mar;25(3):325–9. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul;85(2):177–89. Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K, et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1075–8. Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, et al. Area postrema syndrome: frequency, criteria, and severity in AQP4-IgG-positive NMOSD. Neurology. 2018 Oct;91(17):e1642–51. Hyun JW, Kwon YN, Kim SM, Lee HL, Jeong WK, Lee HJ, et al. Value of area postrema syndrome in differentiating adults with AQP4 vs. MOG antibodies. Front Neurol. 2020 Jun;11:396. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov;68(5):757–61. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, et al. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar;11(3):240–5. Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3 – brainstem involvement – frequency, presentation and outcome. J Neuroinflammation. 2016 Nov;13(1):281. Kunchok A, Krecke KN, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Chen JJ, et al. Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)? Neurology. 2020 Jan;94(2):85–8. Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, et al. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488–90. Ciron J, Sourdrille F, Biotti D, Tchoumi T, Ruiz A, Bernard-Valnet R, et al. Area postrema syndrome: another feature of anti-GFAP encephalomyelitis. Mult Scler. 2020 Feb;26(2):253–5. Lin H, Huang Y, Zeng H, Wang M, Guan S, Chen G, et al. Overlapping clinical syndromes in patients with glial fibrillary acidic protein IgG. Neuroimmunomodulation. 2020 Feb;27(1):69–74. Zhang Y, Bhekharee AK, Zhang X. NMOSD or GFAP astrocytopathy? A case report. Mult Scler Relat Disord. 2020 Aug;43:102202. Adachi H, Shiomi Y, Kimura A, Shimohata T, Yoneda Y, Kageyama Y. A case of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. Rinsho Shinkeigaku. 2021 Jun;61(6):401–4. Gao X, Tang Y, Yang GD, Wei W. Autoimmune glial fibrillary acidic protein astrocytopathy associated with area postrema syndrome: a case report. Front Neurol. 2021 Dec;12:803116. Koh PX, Tay KY, Yeo T, Singh DR, Koh JS, Thirugnanam UN, et al. Glial fibrillary acidic protein astrocytopathy in a patient with recent mRNA SARS-CoV-2 vaccination: coversheet. Neuroimmunol Rep. 2022 Dec;2:100053. Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol. 2019 Jul;332:91–8. Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018 Mar;25(3):477–83. Dumonceau AG, Ameli R, Rogemond V, Ruiz A, Joubert B, Muñiz-Castrillo S, et al. Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology. 2022;98(6):e653–68. Fetter M, Kennard C. 18. Hiccup. 2nd ed. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C, editors. Neurological disorders: course and treatment. Oxford: Elsevier Science; 2003. p. 185–8. Wang Q, Ma C. The onset of autoimmune glial fibrillary acidic protein astrocytopathy with prolonged gastrointestinal symptoms: a case report. Acta Neurol Belg. 2021 Feb;121(1):305–8. McKeon A, Benarroch EE. Glial fibrillary acid protein: functions and involvement in disease. Neurology. 2018 May;90(20):925–30. Hao XT, Wang L, Yan B, Zhou HY. Intractable hiccup caused by spinal cord lesions in demyelination disease. J Spinal Cord Med. 2013 Nov;36(6):711–4. Wang Y, Zhang L, Zhang B, Dai Y, Kang Z, Lu C, et al. Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions. J Neurol. 2014 May;261(5):954–62. Greene CL, Oh DS, Worrell SG, Hagen JA. Hiccups and gastroesophageal reflux disease as seen on high resolution esophageal manometry. Dis Esophagus. 2016 Oct;29(7):883–4. van Durme CM, Idema RN, van Guldener C. Two rare complications of glioblastoma multiforme: persistent hiccup and acquired haemophilia A. Neth J Med. 2008 Jul–Aug;66(7):286–8. Longatti P, Pierluigi L, Basaldella L, Luca B, Moro M, Mario M, et al. Refractory central supratentorial hiccup partially relieved with vagus nerve stimulation. J Neurol Neurosurg Psychiatry. 2010 Jul;81(7):821–2. Tiedt HO, Wenzel R. Persistent hiccups as sole manifestation of right cortical infarction without apparent brainstem lesion. J Neurol. 2013 Jul;260(7):1913–4. Sweeney J, Bodman A, Hall WA. Brain abscess of basal ganglia presenting with persistent hiccups. World Neurosurg. 2018 Apr;112:182–5. Article / Publication Details

First-Page Preview

Received: December 16, 2021
Accepted: March 10, 2022
Published online: April 14, 2022

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 1

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: https://www.karger.com/NIM

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.